CG
AVNS

Colony Group’s Avanos Medical AVNS Stock Holding History

Colony Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3
Closed – – 273
2015
Q4 		$0 Sell
3
-130
-98% -$4.04K ﹤0.01% 777
2015
Q3 		$4K Sell
133
-55
-29% -$1.92K ﹤0.01% 701
2015
Q2 		$8K Sell
188
-541
-74% -$24.3K ﹤0.01% 613
2015
Q1 		$36K Sell
729
-175
-19% -$8.11K ﹤0.01% 458
2014
Q4 		$41K Buy
+904
New +$35.5K ﹤0.01% 473

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Colony Group's AVNS Position: Q1 2016 in Review

Colony Group sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 3 shares.

Colony Group first reported a position in AVNS in Q4 2014 and held it in 5 quarters. The position peaked at $41K in Q4 2014. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Colony Group reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 3 Avanos Medical shares in Q1 2016.
  • Colony Group first reported a position in Avanos Medical in Q4 2014 and held it in 5 quarters.
  • Colony Group's Avanos Medical position peaked at $41K in Q4 2014.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.